Delivery Order SPE2DB22D3501-SPE2DB25FVR66

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALVANCE 500 MG VIALS. The $5,377.68 firm fixed price contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,445.50, is for the delivery of DALVANCE 500 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $36,921.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, for the provision of DALVANCE 500 MG VIALS. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025. There was no set-aside designation used for this contract. AmerisourceBergen holds a...
This federal contract award, valued at $6,474.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of February 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $18,167.59 firm fixed-price delivery order is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product, with a period of performance through February 2025. The contract is not designated as a set-aside and represents part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a $2,541.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DALVANCE 500 MG VIALS, a specialty medication, to support military healthcare programs. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, with an award ID of SPE2DX15D3404 and SPE2DX24F0YDZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $5,204.53 firm fixed-price delivery order is for the pharmaceutical product DALVANCE 500 MG VIALS, with a completion date of November 3, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dalvance 500 mg vials. The contract has a firm fixed price, a ceiling value of $8,962.70, and a period of performance through April 23, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALVANCE 500 MG VIALS. The contract has a ceiling value of $12,171.59 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $6,930.64, is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product. The contract has a completion date of August 7, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVR66
    Delivery Order

This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of DALVANCE 500 MG VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,585.12, has a completion date of May 15, 2025. The contract is not set aside and allows for the supply of a range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This contract award is part of the company's broader role as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/13/25, 11:11 AM